Items tagged with Drug-resistant TB
Cape Town - Local tuberculosis experts are optimistic that a novel TB antibiotic, which is being tested on multidrug-resistant TB sufferers in a Cape Town hospital, could revolutionise treatment of the killer disease.
Enigma Diagnostics, a leader in molecular diagnostic point-of-care infectious disease testing, announces that it has been awarded a second grant from the UK’s innovation agency, the Technology Strategy Board. This grant will support further development of its test for multidrug-resistant tuberculosis (MDR-TB) on its CE Marked Enigma® Mini Laboratory (ML) system.
12.03.14 - Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.
Research led by Colorado State University reveals promising strategy for treating tuberculosis (post)
FORT COLLINS - Research at Colorado State University reveals that even the most intractable cases of tuberculosis might be effectively battled with a new drug cocktail combining conventional antibiotics and nontoxic compounds that mimic those found in some sea sponges.
Public Health England published study results in The Lancet on Tuesday that showed tuberculosis most commonly spreads between people with a history of drug use and within ethnic communities.
18 March 2014 - In the southern African nation of Swaziland, around a quarter of all adults are now HIV positive. With so many now living with compromised immune systems, tuberculosis, which had been in decline for decades, has made a dramatic comeback. Now it has a foothold once more, new mutations are evolving fast, meaning the disease threatens the lives of the healthy as well as those with HIV.
Burnet’s Dr Suman Majumdar has joined leading Australian tuberculosis physicians, Dr Ben Marais, Dr Justin Denholm and Professor Warwick Britton, in calling for urgent action to respond to the global challenge posed by drug-resistant tuberculosis (TB).
India accounts for a quarter of the 8.6 million cases of TB that occur worldwide. India also accounts for a third of the ‘missing 3 million TB cases’ that do not get diagnosed or notified. Not only is TB not going away, we are now seeing severe forms of multidrug-resistant TB (MDR-TB).
A third of tuberculosis (TB) sufferers in Thailand are not receiving proper treatment, increasing the risk of spreading the disease and their chances of becoming resistant to multiple treatment drugs.
MUMBAI: In another first for the city's tuberculosis-control programme, doctors here will be able to use a mobile app to notify the central government of new patients. The Android-based app will be directly linked to the government's online registry of TB patients called Nikshay.
Page 2 of 94 · Total posts: 0←First 1 2 3 Last→